NCT01584050View on ClinicalTrials.gov

Relative Bioavailability of Folic Acid and L-5-Methlytetrahydrofolate

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Vitamin B12 Deficiency
Interventions
DIETARY_SUPPLEMENT

L-5-methyltetrahydrofolate (Metafolin ®)

dosage: 1000 μg, frequency: once daily, duration: 12 weeks

DIETARY_SUPPLEMENT

folic acid

dosage: 1000 μg, frequency: once daily, duration: 12 weeks

DIETARY_SUPPLEMENT

Placebo

frequency: once daily, duration: 12 weeks

Trial Locations (2)

Unknown

University of British Columbia, Vancouver

Universiti Putra Malaysia, Serdang

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT01584050 - Relative Bioavailability of Folic Acid and L-5-Methlytetrahydrofolate | Biotech Hunter | Biotech Hunter